RYR1 and cutaneous mastocytosis: In conclusion, (i) the expression levels of most myo-miRNAs and miRNA-22 are downregulated in muscles of all CM patients; (ii) miRNA-95 expression levels are significantly decreased in CM patients carrying dominant RYR1 mutations; and (iii) foetal muscles show altered expression levels of most of the miRNAs that were investigated.